Given the crucial roles of CLDN12 and CLDN15 in maintaining tight junctions and barrier function, their CNV‐driven expression changes might significantly impact glioma progression through altered cell–cell adhesion and blood–brain barrier integrity [31]. Here, CLDN12 is linked to central nervous system cancer.